Powder: -20°C for 3 years | In solvent: -80°C for 1 year
FR 167653 free base is an orally active p38 MAPK inhibitor and is effective in treating inflammation, relieving trauma, and ischemia-reperfusion injury in vivo. It also is a potent suppressor of TNF-α and IL-1β production via specific inhibition of p38 MAPK activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 |
Description | FR 167653 free base is an orally active p38 MAPK inhibitor and is effective in treating inflammation, relieving trauma, and ischemia-reperfusion injury in vivo. It also is a potent suppressor of TNF-α and IL-1β production via specific inhibition of p38 MAPK activity. |
In vivo | FR 167653 free base (32 mg/kg; i.h.; 24-48 hours) obviously reduces the extent of acute tubular necrosis [1]. |
Molecular Weight | 427.43 |
Formula | C24H18FN5O2 |
CAS No. | 158876-65-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
FR 167653 free base 158876-65-4 Others FR-167653 FR167653 FR 167653 inhibitor inhibit